Close Menu

NEW YORK (360Dx) – Ortho Clinical Diagnostics said this week that it has entered into a strategic relationship with Thermo Fisher Scientific's BRAHMS to develop a procalcitonin assay for use on Ortho's Vitros systems.

Ortho said that it is currently developing the assay for use on Vitros immunodiagnostics and integrated systems for small-, mid-, and high-volume clinical labs.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.